These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 10428376)
1. Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonist. Gelus N; Hamy F; Bailly C Bioorg Med Chem; 1999 Jun; 7(6):1075-9. PubMed ID: 10428376 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains. Gelus N; Bailly C; Hamy F; Klimkait T; Wilson WD; Boykin DW Bioorg Med Chem; 1999 Jun; 7(6):1089-96. PubMed ID: 10428378 [TBL] [Abstract][Full Text] [Related]
3. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition. Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739 [TBL] [Abstract][Full Text] [Related]
4. Discoveries of Tat-TAR interaction inhibitors for HIV-1. Yang M Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863 [TBL] [Abstract][Full Text] [Related]
5. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules. Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258 [TBL] [Abstract][Full Text] [Related]
7. Blocking HIV replication by targeting Tat protein. Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447 [TBL] [Abstract][Full Text] [Related]
8. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA. Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598 [TBL] [Abstract][Full Text] [Related]
9. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049 [TBL] [Abstract][Full Text] [Related]
10. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553 [TBL] [Abstract][Full Text] [Related]
11. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening. Du Z; Lind KE; James TL Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782 [TBL] [Abstract][Full Text] [Related]
12. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA. Long KS; Crothers DM Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative. Richter S; Parolin C; Gatto B; Del Vecchio C; Brocca-Cofano E; Fravolini A; Palù G; Palumbo M Antimicrob Agents Chemother; 2004 May; 48(5):1895-9. PubMed ID: 15105155 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA. Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529 [TBL] [Abstract][Full Text] [Related]
15. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation. Richter S; Cao H; Rana TM Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901 [TBL] [Abstract][Full Text] [Related]
17. Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Aboul-ela F; Karn J; Varani G Nucleic Acids Res; 1996 Oct; 24(20):3974-81. PubMed ID: 8918800 [TBL] [Abstract][Full Text] [Related]
18. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Cordingley MG; LaFemina RL; Callahan PL; Condra JH; Sardana VV; Graham DJ; Nguyen TM; LeGrow K; Gotlib L; Schlabach AJ Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8985-9. PubMed ID: 2247474 [TBL] [Abstract][Full Text] [Related]
19. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Wu F; Garcia J; Sigman D; Gaynor R Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997 [TBL] [Abstract][Full Text] [Related]
20. A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo. Lund LH; Wahren B; Garcia-Blanco MA J Gen Virol; 2003 Mar; 84(Pt 3):603-606. PubMed ID: 12604811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]